Dokkyo Medical University · Unclassified · 糖尿病内分泌・血液内科 病院講師

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Cerebral infarction after switching from roxadustat to daprodustat in a patient with renal anemia., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Cureus., 16, e63942, 2024年2024 · 論文
• Exacerbation in glycemic control by switching from subcutaneous dulaglutide injection to oral semaglutide administration in a patient with type 2 diabetes, who had undergone gastrectomy., Takebayashi K, Harasawa A, Miyake Y, Ujiie A, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J., 3, 303-307, 2024年2024 · 論文
• Analysis of serum levels and DNA methylation of fibroblast growth factor 21 using peripheral bloodderived genomes in patients with obesity., Shinozaki H, Kawai S, Gamo-Kawasaki M, Takei A, Tsujikado K, Fukuda K, Yamauchi M, Hara K, Tsuchiya T, Takebayashi K, Hashimoto K, Endocr J., 71, 907-924, 2024年2024 · 論文
• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity, Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K, Endocr J., 71, 39-44, 2024年2024 · 論文

• Official profile